Belpointe Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,160
| Closed | -$323K | – | 881 |
|
|
2023
Q1 | $323K | Sell |
1,160
-2,137
| -65% | -$591K | 0.02% | 714 |
|
|
2022
Q4 | $913K | Sell |
3,297
-200
| -6% | -$56.5K | 0.06% | 344 |
|
|
2022
Q3 | $933K | Buy |
3,497
+61
| +2% | +$13K | 0.06% | 312 |
|
|
2022
Q2 | $701K | Buy |
3,436
+96
| +3% | +$19.6K | 0.05% | 385 |
|
|
2022
Q1 | $703K | Sell |
3,340
-292
| -8% | -$63.5K | 0.04% | 423 |
|
|
2021
Q4 | $871K | Sell |
3,632
-597
| -14% | -$154K | 0.05% | 356 |
|
|
2021
Q3 | $1.2M | Buy |
4,229
+54
| +1% | +$17.7K | 0.08% | 269 |
|
|
2021
Q2 | $1.45M | Buy |
4,175
+1,162
| +39% | +$352K | 0.1% | 214 |
|
|
2021
Q1 | $843K | Sell |
3,013
-1,107
| -27% | -$299K | 0.07% | 286 |
|
|
2020
Q4 | $1.01M | Buy |
4,120
+2,934
| +247% | +$757K | 0.09% | 248 |
|
|
2020
Q3 | $337K | Buy |
1,186
+234
| +25% | +$65.3K | 0.04% | 404 |
|
|
2020
Q2 | $255K | Buy |
952
+11
| +1% | +$3.31K | 0.03% | 456 |
|
|
2020
Q1 | $298K | Buy |
941
+82
| +10% | +$24.9K | 0.05% | 338 |
|
|
2019
Q4 | $255K | Buy |
859
+91
| +12% | +$25.2K | 0.03% | 475 |
|
|
2019
Q3 | $179K | Sell |
768
-17
| -2% | -$3.96K | 0.03% | 497 |
|
|
2019
Q2 | $184K | Sell |
785
-155
| -16% | -$35.8K | 0.04% | 431 |
|
|
2019
Q1 | $222K | Buy |
940
+119
| +14% | +$37.5K | 0.04% | 292 |
|
|
2018
Q4 | $247K | Sell |
821
-1,297
| -61% | -$414K | 0.06% | 305 |
|
|
2018
Q3 | $748K | Buy |
+2,118
| New | +$729K | 0.12% | 174 |
|
|
2018
Q1 | – | Sell |
-1,989
| Closed | -$634K | – | 359 |
|
|
2017
Q4 | $634K | Sell |
1,989
-1,697
| -46% | -$544K | 0.14% | 168 |
|
|
2017
Q3 | $1.15M | Buy |
+3,686
| New | +$1.09M | 0.27% | 84 |
|
Other funds holding BIIB
